Physiology of Lipid Regulation and Atherosclerosis: Study Notes

Physiology of Lipid Regulation and Atherosclerosis

Introduction

This study guide covers the physiology of lipid transport, the roles of major lipoproteins, and the pathophysiology of atherosclerosis. Understanding these processes is essential for grasping how lipid imbalances contribute to cardiovascular disease.

Hyperlipidemia and Lipoproteins

Definition and Importance

• Hyperlipidemia refers to elevated levels of lipids (cholesterol, triglycerides, phospholipids) in the blood.

• Lipids are transported in the blood as complexes called lipoproteins, which are spherical particles with a surface of phospholipids and proteins, and a core of triglycerides and cholesterol.

• Major types of lipoproteins found in serum include:

  • Low-Density Lipoproteins (LDL)

  • High-Density Lipoproteins (HDL)

  • Very Low-Density Lipoproteins (VLDL)

• Elevations in any lipoprotein type can lead to atherosclerosis, increasing the risk of myocardial infarction (MI) and stroke.

Lipoprotein Structure and Classification

• Lipoproteins are classified by their density, which depends on their protein and lipid content:

  • Higher protein content = higher density

  • Higher lipid content = lower density

• Major lipid types in lipoproteins:

  • Triglycerides (TG)

  • Cholesterol

  • Phospholipids

Lipoprotein Comparison Table

Lipoprotein	Main Lipid Content	Main Function
VLDL	Triglycerides	Delivers TGs to tissues
IDL	Triglycerides & Cholesterol	Intermediate in TG delivery and cholesterol transport
LDL	Cholesterol	Delivers cholesterol to tissues
HDL	Cholesterol	Removes cholesterol from tissues, returns to liver

LDL and HDL: "Bad" and "Good" Cholesterol

Roles in Lipid Transport

• LDL (Low-Density Lipoprotein) carries cholesterol and other lipids from the liver to peripheral tissues and blood vessels. High levels are associated with increased risk of atherosclerosis.

• HDL (High-Density Lipoprotein) carries cholesterol from blood vessels and tissues back to the liver for excretion or recycling. High levels are protective against cardiovascular disease.

• The direction of lipid transport is crucial: cholesterol in transit to blood vessels is harmful, while removal from vessels to the liver is protective.

Mechanisms of Lipid Delivery

• Lipoproteins are soluble in plasma due to their protein coating.

• They bind to specific receptors on cell surfaces to facilitate:

  • Unloading of lipids

  • Endocytosis of the whole lipoprotein

Lipoprotein Metabolism and Pathways

Exogenous and Endogenous Pathways

• Exogenous pathway: Dietary lipids are absorbed in the intestine, packaged into chylomicrons, and delivered to the liver and peripheral tissues.

• Endogenous pathway: The liver synthesizes VLDL, which delivers triglycerides to tissues. As VLDL loses TGs, it is converted to IDL and then LDL, which delivers cholesterol to tissues.

Lipid Unloading and Uptake

• Local lipases (e.g., Lipoprotein Lipase, LPL) on capillary endothelium convert TGs in VLDL to free fatty acids (FAs), which are taken up by muscle and adipose tissue.

• LDL delivers cholesterol to cells by binding to the LDL receptor, followed by endocytosis and lysosomal degradation.

• HDL delivers cholesterol esters to the liver via the Scavenger Receptor Class B Type I (SR-BI) for excretion or recycling.

Key Equations

• Cholesterol transport rate: $\text{Rate}_{\text{cholesterol}} = k[\text{Lipoprotein}][\text{Receptor}]$

Atherosclerosis: Pathophysiology

Development and Progression

• Atherosclerosis is characterized by the build-up of fatty plaques (atheromatous plaques) in the intima of intermediate-sized arteries.

• Endothelial dysfunction precedes structural changes, plaque formation, and clinical events such as heart attack and stroke.

• High plasma LDL-C and low HDL-C ratios increase risk; familial hypercholesterolemia is a genetic risk factor.

Role of Endothelium

• The endothelium lines blood vessels and regulates molecule traffic, vascular tone, coagulation, and repair.

• Endothelial dysfunction increases risk for vascular disorders and atherosclerosis.

Pharmacological Strategies for Hyperlipidemia

General Treatment Approaches

• Lowering blood lipid levels is the primary strategy to reduce risk of atherosclerosis and cardiovascular events.

• Targeting lipoproteins that most influence serum triglyceride levels (e.g., VLDL) is effective for TG-lowering drugs.

• Modulating cholesterol levels impacts LDL and HDL concentrations.

Summary Table: Lipoprotein Functions and Disease Risk

Lipoprotein	Main Cargo	Direction of Transport	Associated Risk
LDL	Cholesterol	Liver to tissues/vessels	"Bad" cholesterol; increases atherosclerosis risk
HDL	Cholesterol	Tissues/vessels to liver	"Good" cholesterol; protective
VLDL	Triglycerides	Liver to tissues	High levels increase TG and atherosclerosis risk

Example

• A patient with high LDL and low HDL is at increased risk for developing atherosclerotic cardiovascular disease.

Additional info: The notes have been expanded to include definitions, mechanisms, and clinical relevance for self-contained study.